Skip to main content
Year archive

OliX Pharmaceuticals, Inc. — 2026 filings

All 21 regulatory filings released by OliX Pharmaceuticals, Inc. (226950) in 2026, sourced directly from the official regulator.

21 Filings
2026 Period
2026 filings (21)
Filing Released Lang
분기보고서 (2026.03)
Interim / Quarterly Report Q1 2026
2026-05-15 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification
2026-04-01 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2026-03-26 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change
2026-03-26 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information
2026-03-26 Korean
사업보고서 (2025.12)
Annual Report FY 2025
2026-03-18 Korean
감사보고서제출
Audit Report / Information FY 2025
2026-03-16 Korean
[기재정정]의결권대리행사권유참고서류
Proxy Solicitation & Information Statement
2026-03-11 Korean
주주총회소집공고
Proxy Solicitation & Information Statement
2026-03-11 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement
2026-03-11 Korean
주주총회소집결의
Proxy Solicitation & Information Statement
2026-03-03 Korean
[기재정정]주식매수선택권부여에관한신고
Regulatory Filings
2026-03-03 Korean
[기재정정]주식매수선택권부여에관한신고
Regulatory Filings
2026-03-03 Korean
[기재정정]주식매수선택권부여에관한신고
Regulatory Filings
2026-03-03 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2026-02-26 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2026-02-26 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2026-02-26 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2026-02-26 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Management Reports
2026-02-12 Korean
기타시장안내 (연구개발 우수기업 매출액 특례적용 관련)
Regulatory Filings
2026-02-12 Korean
투자판단관련주요경영사항 (중추신경계 전달체 기술평가 및 기술도입 옵션 계약 체결)
Regulatory Filings
2026-02-10 Korean